These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6712722)

  • 81. The protective effect of oxime pretreatment upon the inhalative toxicity of sarin and soman in rats.
    Schoene K; Hochrainer D; Oldiges H; Krügel M; Franzes N; Bruckert HJ
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S84-8. PubMed ID: 4092898
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Synthesis and evaluation of small organic molecule as reactivator of organophosphorus inhibited acetylcholinesterase.
    Thakur A; Patwa J; Pant S; Jeet Singh Flora S; Sharma A
    Drug Chem Toxicol; 2024 Jan; 47(1):26-41. PubMed ID: 36514993
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The dependence of the blood level of the oxime HS-6 on the severity of organophosphate poisoning.
    Wolthuis OL; Clason-Van Der Wiel HJ; Visser R
    Eur J Pharmacol; 1976 Oct; 39(2):417-21. PubMed ID: 976329
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Acute behavioural effects of the organophosphates sarin and soman in rats.
    Nieminen SA; Lecklin A; Heikkinen O; Ylitalo P
    Pharmacol Toxicol; 1990 Jul; 67(1):36-40. PubMed ID: 2395814
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Species-related differences in the oxime-induced reactivation of organophosphate-inhibited acetylcholinesterases.
    Luo C; Dawson M; Chambers C; Chilukuri N; Radić Z; Taylor P; Doctor BP; Saxena A
    Chem Biol Interact; 2005 Dec; 157-158():393-4. PubMed ID: 16429528
    [No Abstract]   [Full Text] [Related]  

  • 86. pH effects in the spontaneous reactivation of phosphinylated acetylcholinesterase.
    Lieske CN; Gessner CE; Gepp RT; Clark JH; Meyer HG; Broomfield CA
    Life Sci; 1990; 46(17):1189-96. PubMed ID: 2338884
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Formation of soman (1,2,2-trimethylpropyl methylphosphonofluoridate) via fluoride-induced reactivation of soman-inhibited aliesterase in rat plasma.
    de Jong LP; van Dijk C
    Biochem Pharmacol; 1984 Feb; 33(4):663-9. PubMed ID: 6704183
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Rate constants of carbamylation and decarbamylation of acetylcholinesterase for physostigmine and carbaryl in the presence of an oxime.
    Dawson RM
    Neurochem Int; 1994 Feb; 24(2):173-82. PubMed ID: 8161944
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of repeated intraperitoneal injections of soman on schedule-controlled behavior in the rat.
    Hymowitz N; Brezenoff HE; McGee J; Campbell K; Knight V
    Psychopharmacology (Berl); 1985; 86(4):404-8. PubMed ID: 3929310
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Differences in the toxicity of soman in various strains of mice.
    Clement JG; Hand BT; Shiloff JD
    Fundam Appl Toxicol; 1981; 1(6):419-20. PubMed ID: 7185592
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Influence of atropine upon reactivation and ageing of rat and human erythrocyte acetylcholinesterase inhibited by soman.
    Van Dongen CJ; Elskamp RM; De Jong LP
    Biochem Pharmacol; 1987 Apr; 36(7):1167-9. PubMed ID: 3566809
    [No Abstract]   [Full Text] [Related]  

  • 92. Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. 9. N-Heterocyclic acraldoximes methiodides.
    Franchetti P; Grifantini M; Martelli S
    J Med Chem; 1975 Aug; 18(8):839-42. PubMed ID: 1159702
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Persistence of the anti-cholinesterase soman in rats; antagonism with a non-toxic simulator of this organophosphate.
    Wolthuis OL; Benschop HP; Berends F
    Eur J Pharmacol; 1981 Jan; 69(3):379-83. PubMed ID: 7215436
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Toxicity of soman after repetitive injection of sublethal doses in rat.
    Sterri SH; Lyngaas S; Fonnum F
    Acta Pharmacol Toxicol (Copenh); 1980 Jan; 46(1):1-7. PubMed ID: 7361558
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Carbamates of (hydroxyphenoxy)methyl heteroaromatic salts as acetylcholinesterase inhibitors and protective agents against organophosphorus compounds.
    Sundberg RJ; Dalvie D; Cordero J; Sabat M; Musallam HA
    Chem Res Toxicol; 1993; 6(4):500-5. PubMed ID: 8374048
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Stereoisomers of soman (pinacolyl methylphosphonofluoridate): inhibition of serum carboxylic ester hydrolase and potentiation of their toxicity by CBDP (2-(2-methylphenoxy)-4H-1,3,2-benzodioxaphosphorin-2-oxide) in mice.
    Clement JG; Benschop HP; DeJong LP; Wolthuis OL
    Toxicol Appl Pharmacol; 1987 Jun; 89(1):141-3. PubMed ID: 3590185
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Characterization of monoclonal antibodies that inhibit the catalytic activity of acetylcholinesterases.
    Gentry MK; Moorad DR; Hur RS; Saxena A; Ashani Y; Doctor BP
    J Neurochem; 1995 Feb; 64(2):842-9. PubMed ID: 7830078
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Reduction of blood cholinesterase activities following administration of soman by different routes in guinea-pig.
    Sterri SH; Kloster O; Valdal G
    Acta Pharmacol Toxicol (Copenh); 1982 May; 50(5):326-31. PubMed ID: 7113708
    [TBL] [Abstract][Full Text] [Related]  

  • 99. iso-OMPA-induced potentiation of soman toxicity in rat.
    Gupta RC; Dettbarn WD
    Arch Toxicol; 1987; 61(1):58-62. PubMed ID: 3439875
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Factors modifying the toxicity of organophosphorous compounds including Soman and Sarin.
    Fonnum F; Sterri SH
    Fundam Appl Toxicol; 1981; 1(2):143-7. PubMed ID: 7184780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.